Press ReleaseVELIZY-VILLACOUBLAY, France — January 7, 2026 Declaration of the number of outstanding shares and voting rights as of December 31, 2025 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of December 31, 2025, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,341,806,268 Number of voting rights*: 2,013,578,477 *The tot ...

12月31日，大树云（DSY.US）股价已跌至0．3美元/股，沦为名副其实的"仙股"，全年跌幅约91%，市 值缩水2.88亿美元（折合人民币约20亿元）。 来源：市场资讯 来源：产业资本 据财报数据，2024年7月1日至2025年6月30日期间，大树云营收暴跌65.08% 至255.7万美元，净利润由 盈转亏为-3253万美元（折合人民币亏损约2.2亿），而同期销售费用却暴增26倍，从127.9万美元飙升至 3471万美元。 这意味着，叠加纳斯达克2025年12月收紧的退市新规，这家曾喊出5年"营收100亿元、市值100亿美 元"双百亿目标的企业，如今在持续经营的压力之下，又被退市阴影步步紧逼。 "速成"的个护第一股 2020年，曾担任贵阳市云岩区鲁底驻村第一书记的朱文泉"下海"创业，成立大树云投资控股有限公司。 这家总部位于香港、内地运营中心设在深圳的企业，从诞生之初就将上市作为核心目标——2020年9 月，朱文泉便亮相纽约纳斯达克宣传大屏，高调宣称"预计两年内登陆纳斯达克"。 纳斯达克"个人护理第一股"的光环，终究没能照亮大树云的可持续之路。 彼时，中国女性卫生用品市场正释放巨大潜力：15-49岁育龄女性 ...

Core Viewpoint - Big Tree Cloud Holdings Limited is expanding into new artificial intelligence business lines and restructuring teams to support long-term AI growth [1] Group 1: Executive Changes - Yumao Huang resigned from the board amid business adjustments, and Xiaoxuan Zhu has been appointed as a board director and co-CEO alongside Wenquan Zhu [2] - Xiaoxuan Zhu holds a bachelor's degree in sociology from Peking University and is pursuing a master's at the University of Chicago Booth School of Business [3] - Hu Huang has been appointed as director of the AI Ecosystem Division's technology department, bringing 19 years of experience from companies like VIPKID, Alibaba, and JD.com [4][5] Group 2: Strategic Initiatives - Big Tree Cloud signed a strategic cooperation letter of intent with AI expert Canming Wang, who is among Kaggle's top 50 global competitors [6] - The company aims to capture opportunities in the next wave of tech transformation, as stated by Wenquan Zhu, chairman and co-CEO [6] Group 3: Market Reaction - Following the announcement of its AI expansion, Big Tree Cloud Holdings shares rose by 7.27% to $0.29 [6]

SHENZHEN, China, Jan. 2, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company", or "Big Tree Cloud") (NASDAQ: DSY) today announced its expansion into new AI business lines and the appointment of key talents to support its long-term growth strategy. Due to business adjustments, the Company has decided to restructure the relevant teams. Mr. Yumao Huang has stepped down from the Board of Directors (the "Board"). Mr. Huang has served as a director of the Company since March 2024. His resignation ...

据交易所数据显示，12月17日，大树云(DSY)盘中上涨5.33%，截至22:36，报0.312美元/股，成交1.43万 美元，总市值2968.02万美元。 本文源自：市场资讯 作者：行情君 财务数据显示，截至2024年12月31日，大树云收入总额103.99万美元，同比减少74.99%；归母净利润 187.95万美元，同比增长223.27%。 资料显示，大树云控股有限公司是一家在开曼群岛注册成立的境外控股母公司,主要通过其境内实体子 公司广东省大树云投资控股集团有限公司运营。其子公司是一家以互联网科技为底层基础,以C2M (用户 直连制造) 模式运营的,集产品研发、生产制造、品牌运作、销售运营为一体的集团化企业,旗下拥有深 圳大树云进口贸易有限公司、东莞大树云生活用品有限公司、深圳惊喜云贸易有限公司及江苏、四川、 吉林、辽宁四家分公司。集团在产品上聚焦个人护理用品新消费领域,坚持走自有品牌发展路线,通过搭 建研发体系,将科技赋能产品,生产出中国高端个人护理产品。大树云集团始终秉承"诚信、创新、和谐、 共赢"的企业精神,走出一条自主创新发展之路。 ...

Core Points - Dassault Systèmes announced the total number of outstanding shares and voting rights as of November 30, 2025, with 1,341,782,567 outstanding shares and 2,013,594,540 voting rights [2][4] Group 1 - The number of outstanding shares is reported as 1,341,782,567 [2] - The total number of voting rights is calculated based on the outstanding shares, including those with suspended voting rights [2] - Shareholders are advised to refer to Article 223-11 of the General Regulation for details on declaring crossing of thresholds [2][3]

Core Points - Dassault Systèmes announced the total number of outstanding shares and voting rights as of October 31, 2025, with 1,341,772,015 outstanding shares and 2,013,588,275 voting rights [2][4] Group 1 - The number of outstanding shares is reported as 1,341,772,015 [2] - The total number of voting rights is calculated based on the outstanding shares, including those with suspended voting rights [2] - Shareholders are advised to refer to Article 223-11 of the General Regulation for details on declaring crossing of thresholds [2][3]

Core Viewpoint - Big Tree Cloud Holdings Limited has filed its annual report on Form 20-F for the fiscal year ending June 30, 2025, with the SEC, highlighting its position as a capital platform enterprise in China's personal care industry [1][2]. Company Overview - Big Tree Cloud is positioned as an international capital platform, focusing on integration and investment within China's personal care industry [2]. Financial Reporting - The annual report, which includes audited consolidated financial statements, is available on Big Tree Cloud's website and the SEC's website, with hard copies provided free of charge to shareholders upon request [1].

Financial Performance - The company reported a net loss of US$32.5 million for the year ended June 30, 2025, following net income of US$0.3 million and US$0.6 million for the years ended June 30, 2023 and 2024, respectively [36]. - Negative cash flows from operating activities were recorded at US$1.5 million and US$6.5 million for the years ended June 30, 2024 and 2025, respectively, after positive cash flows of US$8.8 million in 2023 [36]. - For the fiscal year ended June 30, 2025, the company reported negative cash flows from operations of $6.5 million [95]. - The company generated an operating profit of $0.7 million for the fiscal year ended June 30, 2023, but incurred operating losses of $0.03 million and $38.2 million for the fiscal years ended June 30, 2024 and 2025, respectively [95]. Customer and Supplier Concentration - For the fiscal year ended June 30, 2025, four major customers accounted for approximately 35%, 15%, 11%, and 10% of total revenue, indicating a significant customer concentration risk [30]. - One supplier accounted for approximately 18% of total purchases for the fiscal year ended June 30, 2025, highlighting reliance on a limited number of suppliers [32]. Market and Competitive Landscape - The personal care industry is highly competitive, with the company facing challenges from both domestic and international players, impacting market share and financial performance [42]. - The company has engaged in limited marketing activities since inception, resulting in a limited customer base compared to established competitors [41]. - Future revenue generation is uncertain due to potential lack of demand, increasing competition, and macroeconomic challenges [37]. Product Development and Safety - The company emphasizes the importance of product safety and quality, as any loss of consumer confidence could adversely affect brand image and sales [51]. - The company acknowledges that product defects or safety issues could lead to recalls, regulatory actions, and loss of market share [52]. - The company successfully adopted new sterilization technology, enhancing product quality, but risks losing technological advantages as competition increases [40]. Operational Challenges - The company has made significant upfront investments in research and development, service network, and sales and marketing, which may not yield immediate revenue increases [36]. - The company plans to expand into adjacent categories such as facial and body care products, despite potential operational challenges due to inexperience in these areas [50]. - Effective management of growth is critical, as rapid expansion may strain resources and operational systems [59]. - The company faces challenges in attracting and retaining qualified personnel, which is essential for sustaining growth and innovation [62]. Regulatory and Compliance Risks - The company must comply with complex product safety laws and regulations, and failure to do so could result in recalls and penalties, impacting financial condition [74]. - The PRC government has significant authority to influence the company's operations, which could result in adverse changes to business and securities value [110]. - The evolving legal landscape in China presents uncertainties that could materially impact the company's operations and securities value [121]. - The company faces risks from potential administrative penalties for failing to comply with PRC laws and regulations [127]. Financial and Investment Risks - The company may need to raise additional funds for operations and expansion, which could be on unfavorable terms or lead to shareholder dilution [38]. - The average wage level in China has increased, leading to higher labor costs, which may adversely affect profitability if these costs cannot be passed on to customers [161]. - Loans to mainland China subsidiaries are subject to regulations, with limits on outstanding amounts based on either total investment or net assets, which could affect liquidity and expansion capabilities [155]. Shareholder and Governance Issues - Mr. Wenquan Zhu owns 70,000,000 Ordinary Shares, representing approximately 73.66% of the aggregate voting power, which may conflict with the interests of other shareholders [194]. - The company is classified as a "controlled company" under Nasdaq rules, allowing it to rely on exemptions from certain corporate governance requirements [196]. - The company's Amended and Restated Memorandum and Articles of Association contain anti-takeover provisions that could adversely affect shareholders' rights [193]. Cybersecurity and Data Protection - The company collects and processes customer data for analysis, which subjects it to privacy and data protection laws; non-compliance could harm its business [86]. - The company has not experienced material incidents of security breaches as of the date of the report, but remains vulnerable to cyber-attacks and unauthorized access [87][88]. - Non-compliance with data security and cybersecurity laws could lead to liabilities and adversely affect the company's offshore listing [131]. Economic and Geopolitical Factors - Economic conditions in China significantly impact the company's revenues, as it derives nearly all revenue from the Chinese market [98]. - Heightened geopolitical tensions, particularly between the United States and China, may adversely affect trade and investment levels, impacting the company's operations [100]. - Discretionary consumer spending is crucial for the company's product sales, making it vulnerable to economic downturns [99].

Core Insights - Medidata has extended its collaboration with Sanofi to enhance clinical research and patient care through improved processes and data management [1][4] - The partnership aims to leverage Medidata's AI-embedded platform solutions to streamline clinical workflows and reduce costs and delays in drug development [2][4] Company Overview - Medidata is a leading provider of clinical trial solutions, celebrating 25 years of innovation with over 36,000 trials and 11 million patients involved [5] - The company offers a comprehensive platform that integrates analytics-powered insights and has over 1 million registered users across approximately 2,300 customers [5] Collaboration Details - Sanofi will utilize Medidata's expertise in decentralized clinical trials, receiving consulting and operational support as part of the extended agreement [3] - The collaboration focuses on enhancing data quality, improving study design, and accelerating the clinical development process [4]